Advertisement
UK markets closed
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     
  • AIM

    745.67
    +0.38 (+0.05%)
     
  • GBP/EUR

    1.1611
    -0.0072 (-0.61%)
     
  • GBP/USD

    1.2372
    -0.0066 (-0.53%)
     
  • Bitcoin GBP

    51,905.78
    +679.62 (+1.33%)
     
  • CMC Crypto 200

    1,383.15
    +70.53 (+5.37%)
     
  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     
  • DOW

    37,986.40
    +211.02 (+0.56%)
     
  • CRUDE OIL

    83.22
    +0.49 (+0.59%)
     
  • GOLD FUTURES

    2,402.20
    +4.20 (+0.18%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     

Why Shares of BioNTech Slumped Monday

Why Shares of BioNTech Slumped Monday

Shares of vaccine maker BioNTech (NASDAQ: BNTX) were down 2.8% early Monday afternoon after falling as much as 6.4% earlier in the day. Annual earnings per share (EPS) also dropped a bit, from 39.63 euros ($42.76) to 37.77 euros ($40.77). In the long run, BioNTech may still be a good deal.